Jason A. Leverone, Chief Financial Officer at OnKure Therapeutics, Inc. (OKUR), sold 3,122 shares at $3.33 ($9K) on 2025-04-04, disclosed to the SEC on 2025-04-08.
Open-market sale of $9k OKUR by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.33 | 1,278 | $4K | 46.4% |
| 2 | $2.67 | 1,844 | $5K | 53.6% |
| Total | $2.94 avg | 3,122 | $9K | 100% |
| Filing → |
| OKUR | SELL | 2026-03-24 | $3K | — | Filing → |
| OKUR | SELL | 2025-12-23 | $897 | — | Filing → |
| OKUR | SELL | 2025-09-24 | $794 | — | Filing → |